BBT Capital Management’s Chemed CHE Stock Holding History

BBT Capital Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,043	Closed	-$295K	–	166
2018 Q4	$295K	Buy	+1,043	New	+$315K	0.26%	182

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBT Capital Management's CHE Position: Q1 2019 in Review

BBT Capital Management sold out of Chemed (CHE) in Q1 2019, closing a stake of 1,043 shares — an estimated $295K sold.

BBT Capital Management first reported a position in CHE in Q4 2018 and held it in 1 quarter. The position peaked at $295K in Q4 2018. 382 funds tracked by Wall St. Rank hold CHE as of Q1 2019.

BBT Capital Management reported no remaining Chemed position as of Q1 2019 after selling out during the quarter.
BBT Capital Management sold 1,043 Chemed shares in Q1 2019, an estimated $295K.
BBT Capital Management first reported a position in Chemed in Q4 2018 and held it in 1 quarter.
BBT Capital Management's Chemed position peaked at $295K in Q4 2018.
382 funds tracked by Wall St. Rank held Chemed as of Q1 2019.

Based on BBT Capital Management's 13F filing for Q1 2019, filed 10 May 2019.